593 related articles for article (PubMed ID: 28458570)
1. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
2. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.
Scuderi N; Monfrecola A; Dessy LA; Fabbrocini G; Megna M; Monfrecola G
Skin Appendage Disord; 2017 May; 3(2):95-110. PubMed ID: 28560220
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis Suppurativa: Where We Are and Where We Are Going.
Scala E; Cacciapuoti S; Garzorz-Stark N; Megna M; Marasca C; Seiringer P; Volz T; Eyerich K; Fabbrocini G
Cells; 2021 Aug; 10(8):. PubMed ID: 34440863
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents.
Megna M; Bettoli V; Chimenti S; Chiricozzi A; Naldi L; Virgili A; Girolomoni G; Monfrecola G
G Ital Dermatol Venereol; 2015 Dec; 150(6):731-9. PubMed ID: 26513043
[TBL] [Abstract][Full Text] [Related]
5. New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
Harvey LM; Fortson JK
Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review.
Ruggiero A; Martora F; Picone V; Marano L; Fabbrocini G; Marasca C
Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203664
[TBL] [Abstract][Full Text] [Related]
9. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.
Fotiadou C; Vakirlis E; Ioannides D
Clin Cosmet Investig Dermatol; 2016; 9():367-372. PubMed ID: 27799806
[TBL] [Abstract][Full Text] [Related]
10. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of hidradenitis suppurativa.
Hoffman LK; Ghias MH; Lowes MA
Semin Cutan Med Surg; 2017 Jun; 36(2):47-54. PubMed ID: 28538743
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa: A Literature Review Comparing Current Therapeutic Modalities.
Rathod U; Prasad PN; Patel BM; Patel B; Patel C; Gandhi SK; Patel P
Cureus; 2023 Aug; 15(8):e43695. PubMed ID: 37724217
[TBL] [Abstract][Full Text] [Related]
13. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
[TBL] [Abstract][Full Text] [Related]
14. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
[TBL] [Abstract][Full Text] [Related]
15. Comorbidities of hidradenitis suppurativa: A review of the literature.
Cartron A; Driscoll MS
Int J Womens Dermatol; 2019 Dec; 5(5):330-334. PubMed ID: 31909152
[TBL] [Abstract][Full Text] [Related]
16. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
Agnese ER; Tariche N; Sharma A; Gulati R
Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
[TBL] [Abstract][Full Text] [Related]
17. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
18. Biologic therapies for the treatment of hidradenitis suppurativa.
Rosales Santillan M; Morss PC; Porter ML; Kimball AB
Expert Opin Biol Ther; 2020 Jun; 20(6):621-633. PubMed ID: 32077334
[No Abstract] [Full Text] [Related]
19. Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review.
Melchor J; Prajapati S; Pichardo RO; Feldman SR
Skin Appendage Disord; 2024 Jun; 10(3):172-179. PubMed ID: 38835710
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
